Carl Zeiss Meditec Share
Deutsch
Research Coverage

Last updated: 27-01-2012

Reports and Publications
Information for analysts and investors

Bank/AnalystPhoneCurrent RatingPrevious
DZ Bank
Michael Bissinger		+49-69-7 44 74 20 13Buy (27-01-2012)Buy
Berenberg Bank
Scott Bardo		+44-(0)-20-3207 7869Buy (12-01-2012)Buy
Cheuvreux
Oliver Reinberg		+49-69-47 89 75 26Underperform (12-01-2012)Underperform
equinet Bank AG
Edouard Aubéry		+49-69-58 99 74 39Accumulate (09-12-2011)Accumulate
Deutsche Bank
Uwe Schupp		+49-69-91 03 19 55Hold (06-12-2011)Hold
HSBC
Jan Keppeler		+49-211-9 10 24 46Overweight (02-12-2011)Overweight
Commerzbank
Volker Braun		+49-69-13 64 76 59Buy (01-12-2011)Buy
LBBW
Volker Stoll		+49-711-12 7 070568Buy (30-11-2011)Buy
Jefferies
Stephan Gasteyger		+44-(0)-20 7029 8703Buy (31-08-2011)Buy
Nord/LB
Holger Fechner		+49-511-3 61 53 05Buy (15-08-2011)Buy
J.P. Morgan Cazenove
David Adlington		+44-(0)-20-71 55 66 24 Neutral (12-08-2011)Neutral
Fairesearch
Martin Schnee		+49-6173 99 59 513Buy (17-08-2010)Hold

Please note:

Banks and securities firms use different terms for their equity ratings.

The information contained in the table is based on publicly available sources that we consider reliable but for which we do not assume any liability. In particular, we do not guarantee that the information is complete, accurate or up-to-date. All ratings are based on opinions given by the analysts in question. These do not necessarily reflect the opinion of Carl Zeiss Meditec AG. The assessments may change at any time without prior notice. Exemption from liability applies to Carl Zeiss Meditec AG; it does not refer to the correct rendering of the information based on external sources, in particular public sources.

Analyst assessments relating to Carl Zeiss Meditec AG shares are only revised each quarter and are therefore not continually updated.


Recommend this page